lipoteichoic-acid and Thrombosis

Impaired healing is common in wounds infected with the major human pathogen Staphylococcus aureus, although the underlying mechanisms are poorly understood. Here, we show that S. aureus lipoteichoic acid (LTA) inhibits platelet aggregation caused by physiological agonists and S. aureus and reduced platelet thrombus formation in vitro. The presence of D-alanine on LTA is necessary for the full inhibitory effect. Inhibition of aggregation was blocked using a monoclonal anti-platelet activating factor receptor (PafR) antibody and Ginkgolide B, a well-defined PafR antagonist, demonstrating that the LTA inhibitory signal occurs via PafR. Using a cyclic AMP (cAMP) assay and a Western blot for phosphorylated VASP, we determined that cAMP levels increase upon platelet incubation with LTA, an effect which inhibits platelet activation. This was blocked when platelets were preincubated with Ginkgolide B. Furthermore, LTA reduced hemostasis in a mouse tail-bleed assay.

Topics: Animals; Antibodies, Monoclonal; Bleeding Time; Blood Platelets; Calcium; Cyclic AMP; Ginkgolides; Humans; Lactones; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Platelet Activation; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Staphylococcus aureus; Teichoic Acids; Thrombosis